
RELUGOLIX 120 mg (Rexigo) is a prescription hormone therapy medicine used to treat advanced prostate cancer in adults. It belongs to a class of medicines called gonadotropin-releasing hormone (GnRH) receptor antagonists. By lowering testosterone levels, relugolix helps slow the growth and spread of prostate cancer cells. It is taken orally once daily under the supervision of an oncologist.
| Generic name | RELUGOLIX |
| Strength | 120 mg |
| Manufacturer | Zydus |
| Package size | 30 Tablets |
| Used for | Advanced prostate cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Relugolix 120 mg works by blocking GnRH receptors in the pituitary gland. This reduces the release of hormones that stimulate testosterone production in the testes. Since many prostate cancer cells depend on testosterone to grow, lowering testosterone levels helps slow the progression of the disease.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.